These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13527682)

  • 1. [Effects of a heparinoid extract on the blood lipoprotein pattern and cholesterol level].
    PERUZY AD; SERENO L
    Rass Fisiopatol Clin Ter; 1957 Dec; 29(12):1363-74. PubMed ID: 13527682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of a heparinoid extract on the total serum cholesterol and the alpha and beta lipoprotein fractions].
    MANCINI M; D'ANDREA L; ORIENTE P; GUERRIERI R; MAIORANO G
    Minerva Med; 1960 Feb; 51():389-91. PubMed ID: 14420509
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies by ultracentrifuge and paper electrophoresis on the effects of heparin and heparinoid substance on the lipoproteins in the serum of cholesterol-fed rabbits.
    NAKAMURA H; FUJITA H; OKUYAMA F
    Jpn J Physiol; 1956 Feb; 5(Suppl):375-81. PubMed ID: 13318784
    [No Abstract]   [Full Text] [Related]  

  • 4. A trial with a physiological heparinoid in some sclerotic chorioretinopathies. An evaluation based on serum cholesterol and lipoprotein values and on clinical ocular findings.
    VANNAS S; KRAUSE U
    Acta Ophthalmol (Copenh); 1961; 39():466-74. PubMed ID: 13780180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of a heparinoid extract on serum beta-lipoproteins and cholesterol in neurological patients. Observations on the Kunkel phenol test].
    MASTROGIOVANNI PD
    Rass Neuropsichiatr; 1960; 14():199-211. PubMed ID: 13767991
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the clearing action of 16 alpha-Chloroestrone-3-methyl ether and heparinoid substances].
    LEGNANI F; GIUDICI G
    Rass Giuliana Med; 1959 Aug; 15():235-7. PubMed ID: 14415324
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE USE OF HEPARINOID IN THE TREATMENT OF PATIENTS WITH CORONARY ATHEROSCLEROSIS].
    KOROCHKIN IM
    Klin Med (Mosk); 1963 Oct; 41():49-55. PubMed ID: 14140171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a heparinoid extract on the blood lipids and basal thrombodensitogram].
    Ferri F; D'Agostino F; D'Onofrio E
    Minerva Med; 1973 Jan; 64(6):272-7. PubMed ID: 4120079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Precipitation of blood beta-lipoproteins by heparin and synthetic heparinoids at pH5].
    BURSTEIN M
    C R Hebd Seances Acad Sci; 1957 Jul; 245(5):586-8. PubMed ID: 13461417
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of intravenous heparin and mepesulfate on cholesterol partition and the lipoprotein pattern.
    MOSES C
    Angiology; 1954 Aug; 5(4):312-3. PubMed ID: 13181010
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective precipitation beta blood lipoproteins by heparin and synthetic heparinoids in the presence of calcium chloride].
    BURSTEIN M; SAMAILLE J
    J Physiol (Paris); 1957; 49(1):83-6. PubMed ID: 13449746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

  • 16. [The normalizing activity on the blood cholesterol and on the lipoprotein picture of a heparin preparation by deep subcutaneous route].
    GIORDANO G; TURRISI E; EGIDIO G
    Minerva Med; 1961 Sep; 52():3141-4. PubMed ID: 13898819
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect on fat metabolism of a new heparinoid of fungal origin.
    Tamási G; Cseh G; Szabó IK; Villányi K
    Acta Physiol Acad Sci Hung; 1968; 33(2):205-12. PubMed ID: 4175991
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes of blood cholesterol and lipid level in atherosclerotic patients treated with a new heparinoid lacking anticoagulant action].
    SABELLA G; DE SIMONE M
    Clin Ter; 1960 Apr; 18():395-412. PubMed ID: 14440551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.